Low-dose calcipotriol can elicit wound closure, anti-microbial, and anti-neoplastic effects in epidermolysis bullosa keratinocytes
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2045-2322
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Low-dose calcipotriol can elicit wound closure, anti-microbial, and anti-neoplastic effects in epidermolysis bullosa keratinocytes ; volume:8 ; number:1 ; day:7 ; month:9 ; year:2018 ; pages:1-14 ; date:12.2018
Scientific reports ; 8, Heft 1 (7.9.2018), 1-14, 12.2018
- Urheber
-
Guttmann-Gruber, Christina
- Beteiligte Personen und Organisationen
-
Tockner, Birgit
Scharler, Cornelia
Hüttner, Clemens
Common, John E.
Tay, Angeline S. L.
Denil, Simon L. I. J.
Klausegger, Alfred
Trost, Andrea
Breitenbach, Jenny
Schnitzhofer, Peter
Hofbauer, Peter
Wolkersdorfer, Martin
Diem, Anja
Laimer, Martin
Strunk, Dirk
Bauer, Johann W.
Reichelt, Julia
Lang, Roland
Piñón Hofbauer, Josefina
SpringerLink (Online service)
- DOI
-
10.1038/s41598-018-31823-6
- URN
-
urn:nbn:de:101:1-2018103121120598788217
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:50 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Guttmann-Gruber, Christina
- Tockner, Birgit
- Scharler, Cornelia
- Hüttner, Clemens
- Common, John E.
- Tay, Angeline S. L.
- Denil, Simon L. I. J.
- Klausegger, Alfred
- Trost, Andrea
- Breitenbach, Jenny
- Schnitzhofer, Peter
- Hofbauer, Peter
- Wolkersdorfer, Martin
- Diem, Anja
- Laimer, Martin
- Strunk, Dirk
- Bauer, Johann W.
- Reichelt, Julia
- Lang, Roland
- Piñón Hofbauer, Josefina
- SpringerLink (Online service)
Ähnliche Objekte (12)
Analysis of apoptosis related genes in nurses exposed to anti-neoplastic drugs
New anti-neoplastic drug test using in vitro model: what to be concern?
The anti-neoplastic effect of doxycycline in osteosarcoma as a metalloproteinase (MMP) inhibitor: a systematic review
Anti-neoplastic sulfonamides alter the metabolic homeostasis and disrupt the suppressor activity of regulatory T cells
Early Systemic Anti-neoplastic Treatment Post SARS-CoV-2 Infection in Patients with Breast Cancer
Evaluation of in vitro and in vivo anti-inflammatory activity of biologically active phospholipids with anti-neoplastic potential in porcine model
Innovative substance 2250 as a highly promising anti-neoplastic agent in malignant pancreatic carcinoma - in vitro and in vivo
Treatment of unresectable stage IV metastatic melanoma with aviscumine after anti-neoplastic treatment failure: a phase II, multi-centre study
Development of a claims-based risk-scoring model to predict emergency department visits in older patients receiving anti-neoplastic therapy
Pre-clinical investigation of carnosine’s anti-neoplastic effect on glioblastoma: uptake, signal transduction, gene expression and tumour cell metabolism
Anti-neoplastic action of Cimetidine/Vitamin C on histamine and the PI3K/AKT/mTOR pathway in Ehrlich breast cancer
Chemosensitivity assay in mice prostate tumor: Preliminary report of flow cytometry, DNA fragmentation, ion ratiometric methods of anti-neoplastic drug monitoring
Analysis of apoptosis related genes in nurses exposed to anti-neoplastic drugs
New anti-neoplastic drug test using in vitro model: what to be concern?
The anti-neoplastic effect of doxycycline in osteosarcoma as a metalloproteinase (MMP) inhibitor: a systematic review
Anti-neoplastic sulfonamides alter the metabolic homeostasis and disrupt the suppressor activity of regulatory T cells
Early Systemic Anti-neoplastic Treatment Post SARS-CoV-2 Infection in Patients with Breast Cancer
Evaluation of in vitro and in vivo anti-inflammatory activity of biologically active phospholipids with anti-neoplastic potential in porcine model
Innovative substance 2250 as a highly promising anti-neoplastic agent in malignant pancreatic carcinoma - in vitro and in vivo
Treatment of unresectable stage IV metastatic melanoma with aviscumine after anti-neoplastic treatment failure: a phase II, multi-centre study
Development of a claims-based risk-scoring model to predict emergency department visits in older patients receiving anti-neoplastic therapy
Pre-clinical investigation of carnosine’s anti-neoplastic effect on glioblastoma: uptake, signal transduction, gene expression and tumour cell metabolism
Anti-neoplastic action of Cimetidine/Vitamin C on histamine and the PI3K/AKT/mTOR pathway in Ehrlich breast cancer
Chemosensitivity assay in mice prostate tumor: Preliminary report of flow cytometry, DNA fragmentation, ion ratiometric methods of anti-neoplastic drug monitoring
Analysis of apoptosis related genes in nurses exposed to anti-neoplastic drugs
New anti-neoplastic drug test using in vitro model: what to be concern?
The anti-neoplastic effect of doxycycline in osteosarcoma as a metalloproteinase (MMP) inhibitor: a systematic review
Anti-neoplastic sulfonamides alter the metabolic homeostasis and disrupt the suppressor activity of regulatory T cells
Early Systemic Anti-neoplastic Treatment Post SARS-CoV-2 Infection in Patients with Breast Cancer
Evaluation of in vitro and in vivo anti-inflammatory activity of biologically active phospholipids with anti-neoplastic potential in porcine model
Innovative substance 2250 as a highly promising anti-neoplastic agent in malignant pancreatic carcinoma - in vitro and in vivo
Treatment of unresectable stage IV metastatic melanoma with aviscumine after anti-neoplastic treatment failure: a phase II, multi-centre study
Development of a claims-based risk-scoring model to predict emergency department visits in older patients receiving anti-neoplastic therapy
Pre-clinical investigation of carnosine’s anti-neoplastic effect on glioblastoma: uptake, signal transduction, gene expression and tumour cell metabolism
Anti-neoplastic action of Cimetidine/Vitamin C on histamine and the PI3K/AKT/mTOR pathway in Ehrlich breast cancer